Therapeutic efficacy of an alpha-particle emitter labeled anti-GD2 humanized antibody against osteosarcoma—a proof of concept study is a research paper published in European Journal of Nuclear Medicine and Molecular Imaging (2023). On theSindex it has a DataRank of 0.345. It has been cited 9 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.345
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: R01 CA116477
National Institutes of Health
Grant: R01 CA187037
National Institutes of Health
Grant: R01 CA239124
National Institutes of Health
Grant: 5R01CA239124-05
MRI-Guided Cryoablation and Imaging-Guided Intratumoral Delivery of STING Agonist Immunotherapy to Target Localized and Metastatic Canine Osteosarcoma
National Institutes of Health
Grant: 5R01CA116477-08
Dose-Response in Radionuclide Therapy
National Institutes of Health
Grant: 5R01CA187037-02
Combined Biologic and Radiopharmaceutical Therapy of Breast Cancer
FWCI
1.55
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals